Aeterna nach dem Split

Das macht das Ganze natürlich schon schmackhafter...MERGER :-D  

haben sich ja einige über den Doddi aufgeregt wegen seiner KE´s... und ich find gut das er sich erfahrene Leute holt..  

Schlimmer geht das noch?

Wenn du die Profile der Herren liest, denke das man sich nun Professionelle Hilfe an Bord geholt hat, um die gesteckten Ziele, siehe Posting #2587 in diesem Jahr zu erreichen.  

eure Augen sind gefährdet! Gleich geht das grüne Flackern am Bildschirm wieder los. Habe mir schon mal die rosarote Brille aufgesetzt.  

Karneval ist doch erst kommende Woche.

Bist wohl ein Long-Time Karnevalist.

Bloß nicht "blenden" lassen.

Zucken könnte die gute alte Aeterna ja mal wieder, aber mehr...  

AEterna Zentaris Inc. Echtzeit-Börsenkurse
$3.2099*  0.09993.21%  

AEterna Zentaris Inc. Real Time Stock Quotes

09:36:14 $ 3.18   300
09:34:44 $ 3.1706   600
09:33:08 $ 3.2099   330
09:32:56 $ 3.1747   350
09:32:16 $ 3.13   100
09:32:16 $ 3.13   100
09:31:06 $ 3.09   100
09:31:06 $ 3.09   100
09:31:06 $ 3.10   1,520
09:31:06 $ 3.09   180
09:30:00 $ 3.09   58
09:30:00 $ 3.09   30
09:30:00 $ 3.09   74
09:30:00 $ 3.09   230
09:30:00 $ 3.09   719
09:30:00 $ 3.09   1,081
09:30:00 $ 3.09   1
09:30:00 $ 3.10   300
09:30:00 $ 3.09   46
09:30:00 $ 3.09   100

Read more: http://www.nasdaq.com/symbol/aezs/time-sales#ixzz3ye0HxlgG
 

                              §  

bei dem Umfeld heute.... Da ist es kein Wunder.
Heute ist wohl jede einzelne Aktie weltweit im plus.

Der Tag hat wohl jedes Depot heute entzückt.  

Background
Mr. Michael Cardiff, also known as Mike, ICD.D has been the Chief Executive Officer and President of Accelerents Inc., since 2003. Mr. Cardiff serves as the Chief Executive Officer and Partner for Imperial Capital Corporation. He serves as an Advisor to several technology companies and a Private Equity firm. He has extensive experience in strategic planning, sales and marketing. Mr. Cardiff served as the President and Chief Executive Officer of Fincentric Corporation (formerly, Prologic Computer Corporation) from 1999 to 2003. He served as an Executive Vice President of Financial Services with EDS Canada Inc., from 1994 to 1999, where he was responsible for all of its business with financial institutions in Canada. He served as the President and Chief Executive Officer of INEA Corporation. He has been a Director at Hydrogenics Corporation since November 2007, and Software Growth Inc since April 2006. Mr. Cardiff has been an Independent Director of Husky Injection Molding Systems Ltd., since December 7, 2006. He serves as a Member of Ace Tech and Institute of Corporate Directors. He served as a Director of Fincentric from 1999 to 2003. He served as Corporate Director of Solcorp, Visible Genetics, Spectra Security Software Visible Decisions and The Toronto Film Festival and Roy Thompson Hall. He served as a Director of Burntsand Inc since February 5, 2002. He served as a Director of Descartes Systems Group Inc. from June 26, 2007 to June 2, 2011. Mr. Cardiff received many awards including A Canadian Export Life Time Achievement Award. He was named a finalist in Ernst & Young's 2001 Entrepreneur of the Year Awards and in 1998 was also recognized as one the country's most successful young leaders with a "Top 40 Under 40 Award".  

Ken Newport
Former President, CroMedica Global Inc.

Ken Newport is an entrepreneur and life sciences business executive. As a graduate from the University of Waterloo and a Chartered Accountant, Mr. Newport had early success in the financial services industry and served as a partner in a Chartered Accounting firm. His focus changed to life sciences in the mid nineties with the formation of CroMedica Global Inc., a contract research organization. As co-founder and President he witnessed CroMedica's growth to 600 employees within six years. By the time that CroMedica merged with PRA International Inc. in 2002 CroMedica had annual revenues of over $40 million with 13 offices in 9 countries. The combined company became one of the 5 largest contract research organizations in the world with 2,600 employees. Mr. Newport served as a Senior Vice President and Executive Committee member for the last three years until his recent retirement. Mr. Newport was also a founding member of Global Biomedical Capital Corporation, Zelos Therapeutics Inc., Prime Trials Inc. and other life science organizations. He currently serves as the Chairman of the Ottawa Life Sciences Council  

Wie war der Spruch ?

Der stete Tropfen höhlt die Nuss !
Und nach 10Mio Tropfen, ist es dann eine Hohlnuss !

So in etwa ging der glaube.

Ergo, jede positive anmutende Meldung bringt etwas mehr Vertrauen.
AEZS ist scheinbar auf einem guten Weg, seine Ziele ernsthaft zu verfolgen.

Eine Garantie gibt es natürlich nicht.  

Steht alles in Posting #2595 in Deutsch schon.  

Eher Fehlerbeseitigung aus der Vergangenheit.  

76.387 242 T  

                              §  

heisst das die Wandele nimmt ein Ende ?? hmmm...  

Vor dem Split ging das besser.

Am Tag mal ein, zweimal den ganzen Bestand durch, aber jetzt...

Scheinbar zur Zt. nicht lohnenswert.  

 

Bin nicht so ein Warrant Speziallist, aber der Kurs wirft wahrscheinlich zu wenig Gewinn ab,

wenn überhaupt.

Daher "lahmt" die Ente zur Zeit massiv.  

muss mich mal in die Warrantwelt einlesen :-)  

Fteitag abend !!
Gruss Tommy  

https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=AEZS  

http://ih.advfn.com/p.php?pid=nmona&article=70180448  

klarokaro